Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 16, 2004

View Archived Issues

Therapeutic benefits of statins in patients with CHD and metabolic syndrome

Effects of beta3-adrenoceptor agonist KTO-7924 on insulin secretion and adipose tissue

Three-year grant supports SARS vaccine work at AlphaVax

Pivotal trial of NovaCaps given green light by EMEA

Genetic variant identified in systemic lupus erythematosus

New anti-Dengue virus antibodies claimed by Novartis and Scripps researchers

New anti-IL-1beta antibodies and their use reported by Applied Molecular Evolution

Novel PTP inhibitors covered by Procter & Gamble patent

Dual tachykinin NK2/NK3 antagonists designed at GSK

Scientists at LEK and the Univeristy of Ljubljana design novel thrombin/factor Xa inhibitors

German scientists present isoquinoline-based agents for infections, cancer, etc.

Wyeth researchers present novel 5-HT6 receptor ligands

IL-8 inhibitor prevents ischemia/reperfusion injury after kidney transplantation

Insight into mechanism of immunosuppressive effects of beta-SQAG9

Selective glucocorticoid receptor agonist presents less potential for adverse side effects

Protective cardiovascular effects of prostaglandin E2 receptor subtype EP4 agonist

Alvesco approved in Brazil and Mexico

Aerosolized hydroxychloroquine enters clinical testing for respiratory diseases

Perlegen receives grant for whole genome association study of Alzheimer's

DOR BioPharma receives grant for ricin toxin vaccine work

Lilly advances therapeutic antibody into clinic

Proof of concept in Genmab/Roche collaboration

Remune induces HIV-specific immunity in drug-naive patients

Recordati signs European license agreement for rupatadine

PRX-00023 successfully completes phase I single and multiple dose studies

Sangamo updates ZFP programs

New study tests ZoMaxx drug-eluting coronary stent

DOV and Merck & Co. close agreement for novel triple uptake inhibitors

Clinical studies assess the cognitive effects of donepezil in AD, vascular dementia and HD

MMP and PKC inhibition reduce cutaneous contact hypersensitivity

VLA-1 receptor a target for psoriasis treatment

Antiinflammatory effects of Celacade in a model of myosin-induced myocarditis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...